Hager Bioscience, LLC

HAGER BIOSCIENCES, LLC is a preclinical-stage drug discovery company based on innovative medicinal chemistry capabilities that provides sought-after therapeutic leads for unmet medical needs. Hager’s discovery fragment pharmacophore platform, FragPhore®, provides a competitive advantage for the efficient and rapid optimization of a drug candidate’s medicinal chemistry, improvement in pharmaceutical properties, and enhancement of intellectual property.